C World Wide Group Holding A Abb Vie Inc. Transaction History

C World Wide Group Holding A

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 02, 2019	SELL	$65.7 - $83.98 $8.26 Million - $10.6 Million	-125,780 Closed	0 $0
Q3 2018 Nov 05, 2018	SELL	$88.91 - $98.84 $1.56 Million - $1.73 Million	-17,491 Reduced 12.21%	125,780 $11.9 Million
Q3 2017 Nov 06, 2017	BUY	$69.85 - $89.22 $10 Million - $12.8 Million	143,271	143,271 $12.7 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of C World Wide Group Holding A, based on Form 13F filings with the SEC.

Stay updated on C World Wide Group Holding A with notifications on news.